H.R. 5592: Childhood Genital Mutilation Prevention Act
The Childhood Genital Mutilation Prevention Act is proposed legislation that aims to prohibit certain medical treatments related to gender, specifically for individuals under the age of 18. Here are the key elements of the bill:
Prohibited Treatments for Minors
The bill makes it unlawful for anyone to perform or attempt to perform gender-related medical treatment on minors. The consequences for violating this could include fines or imprisonment for up to 10 years, under specific circumstances that involve interstate commerce or communications related to the treatment.
Circumstances for Violation
The following circumstances are identified where the prohibition applies:
- If either the offender or the minor traveled across state lines or internationally in relation to the treatment.
- If the offender used any means of interstate commerce to arrange for or provide the treatment.
- If payment for such treatment was made using any interstate commerce instrumentality.
- Communications related to the treatment were transmitted through interstate commerce.
- Any object used during the treatment traveled in interstate commerce.
- If the treatment occurred in a special maritime or territorial jurisdiction of the U.S.
- If the treatment affected interstate commerce in any way.
Exceptions to the Prohibition
There are exceptions to this prohibition whereby gender-related medical treatments may be allowed. Such treatments can be performed if they are aimed at addressing:
- Disorders of sex development confirmed by a physician through genetic or biochemical testing.
- Irresolvably ambiguous biological sex characteristics.
- Conditions resulting from previously provided gender-related medical treatment that have caused or worsened an infection, injury, disease, or disorder.
Also, minors seeking such treatments will not be penalized under this act.
Medicare and Federal Funding Regulations
The bill also seeks to amend the Social Security Act, specifically:
- It will add provisions to exclude gender-related medical treatment for minors from coverage under Medicare.
- It mandates that providers who furnish such medical treatment will be excluded from participating in Medicare.
- Federal funding will not be allocated for any gender-related medical treatment provided to minors.
Definitions
In the context of this bill:
- Gender-related medical treatment refers to medical interventions intended to alter or affirm an individual's perceived gender, encompassing both surgical procedures and hormone treatments.
- Minor is defined as anyone under the age of 18.
- Gender refers to the biological distinction between males and females, rather than gender identity or expression.
Implementation Timeline
The provisions related to Medicare exclusions are set to take effect 90 days after the bill is enacted.
Relevant Companies
- None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
5 bill sponsors
Actions
2 actions
Date | Action |
---|---|
Sep. 26, 2025 | Introduced in House |
Sep. 26, 2025 | Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.